We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK icon
Splunk Inc
SPLK
+$446M
3
HES icon
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X icon
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RCUS icon
251
Arcus Biosciences
RCUS
$3.11B
$1.02M 0.03%
53,246
-46,166
-46% -$738K
2022 Q2
6 quarters
EXR icon
252
Extra Space Storage
EXR
$28.4B
$1.01M 0.03%
6,325
-78,576
-93% -$9.99M
2021 Q1
11 quarters
SYRS icon
253
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.01M 0.03%
+130,000
New +$445K
2023 Q4
0 quarters
NOW icon
254
ServiceNow
NOW
$146B
$999K 0.03%
7,070
-30,430
-81% -$3.84M
2023 Q3
1 quarter
PTCT icon
255
PTC Therapeutics
PTCT
$5.4B
$994K 0.03%
36,052
-6,549
-15% -$150K
2022 Q4
4 quarters
AKTS icon
256
DELISTED
Akoustis Technologies Inc
AKTS
$984K 0.03%
1,180,000
+980,000
+490% +$659K
2022 Q4
4 quarters
HLVX icon
257
DELISTED
HilleVax
HLVX
$980K 0.03%
61,059
-53,419
-47% -$710K
2022 Q2
6 quarters
VRNA
258
DELISTED
Verona Pharma
VRNA
$965K 0.03%
48,533
-39,095
-45% -$577K
2022 Q3
5 quarters
RVNC icon
259
DELISTED
Revance Therapeutics, Inc.
RVNC
$964K 0.03%
109,667
+20,867
+23% +$171K
2023 Q3
1 quarter
AXSM icon
260
Axsome Therapeutics
AXSM
$8.82B
$949K 0.03%
11,922
-13,813
-54% -$923K
2022 Q1
7 quarters
TEVA icon
261
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$940K 0.03%
90,017
-94,983
-51% -$887K
2023 Q3
1 quarter
AXGN icon
262
Axogen
AXGN
$2.12B
$940K 0.03%
137,575
-101,621
-42% -$565K
2022 Q1
7 quarters
JD icon
263
JD.com
JD
$36.6B
$939K 0.03%
+32,500
New +$881K
2023 Q4
0 quarters
WH icon
264
Wyndham Hotels & Resorts
WH
$5.5B
$919K 0.03%
11,428
-160,443
-93% -$12.1M
2020 Q3
13 quarters
IOVA icon
265
CALL
Iovance Biotherapeutics
IOVA
$6.62B
$900K 0.03%
330,000
+100,000
+43% +$523K
2023 Q3
1 quarter
IMUX icon
266
Immunic
IMUX
$112M
$900K 0.03%
60,023
-16,146
-21% -$198K
2022 Q1
7 quarters
PTON icon
267
PUT
Peloton Interactive
PTON
$2.25B
$899K 0.03%
1,037,500
– –
2023 Q1
3 quarters
SILK icon
268
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$890K 0.03%
72,556
+26,028
+56% +$244K
2022 Q1
7 quarters
SAVE icon
269
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$885K 0.03%
300,000
-150,000
-33% -$2.16M
2022 Q3
5 quarters
META icon
270
Meta Platforms (Facebook)
META
$1.83T
$885K 0.03%
2,500
-5,000
-67% -$1.63M
2023 Q1
3 quarters
ETNB icon
271
DELISTED
89bio
ETNB
$883K 0.03%
79,075
-19,763
-20% -$182K
2022 Q3
5 quarters
TRIS icon
272
DELISTED
Tristar Acquisition I Corp.
TRIS
$870K 0.03%
80,656
-36,254
-31% -$390K
2021 Q4
8 quarters
SUI icon
273
Sun Communities
SUI
$13.9B
$853K 0.03%
6,379
-40,122
-86% -$4.83M
2018 Q2
22 quarters
IOVA icon
274
Iovance Biotherapeutics
IOVA
$6.62B
$846K 0.03%
104,059
-137,915
-57% -$722K
2022 Q1
7 quarters
LYV icon
275
PUT
Live Nation Entertainment
LYV
$39.7B
$845K 0.03%
229,500
+192,000
+512% +$16.5M
2023 Q3
1 quarter
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.